Comparison Chart ImmuPharma plc

Equities

Delayed London S.E. Other stock markets 11:35:06 2024-05-24 am EDT			5-day change	1st Jan Change
2.2 ^GBX	+2.56%		-1.79%	+31.97%

Apr. 29	Immunovia Announces the Appointment of Lisa Fordas as Clinical Laboratory Director	CI
Apr. 02	Immupharma jumps amid new IP strategy for P140 technology platform	AN

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

		Sector	Change	5d. change	1st Jan change	1-year change	5-years change	Capi.	ST	MT	LT
	IMMUPHARMA PLC	Other Biotechnology & Medical Research	+2.56%	-1.79%	+31.97%	-26.91%	-77.73%	11.7M